[Up-to-date approach to treatment of inflammatory infections in the maxillofacial region].
Cycloferon, a prospective interferon inductor, and the mechanism of its action were characterized. Its formulation for external use as liniment was developed. The pharmacotherapeutic effect of the drug in the treatment of paradontitis was shown. The drug efficacy in herpetic lesions of the mouth and lips mucosa was observed. The use of cycloferon in the treatment of the buccal mucosa affections in HIV-infected subjects was substantiated.
Romantsov
M G
MG
Kovalevskiĭ
M A
MA
Iaremenko
A I
AI
Grigorian
S S
SS
Kovalenko
A L
AL
D000166:Acridines / Q000008:administration & dosage / Q000627:therapeutic use*; D000287:Administration, Topical; D006801:Humans; D007369:Interferon Inducers / Q000008:administration & dosage / Q000627:therapeutic use*; D008038:Liniments; D008439:Maxillary Diseases / Q000188:drug therapy* / Q000382:microbiology / Q000821:virology; D010510:Periodontal Diseases / Q000188:drug therapy* / Q000382:microbiology; D016032:Randomized Controlled Trials as Topic; D013283:Stomatitis, Herpetic / Q000188:drug therapy*; D016896:Treatment Outcome
D000166:Acridines; D007369:Interferon Inducers; D008038:Liniments; C026430:10-carboxymethyl-9-acridanone